Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases.
about
Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapyThe use of the Godin-Shephard Leisure-Time Physical Activity Questionnaire in oncology research: a systematic reviewThe potential role of exercise in neuro-oncologyImproving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies.The effects of resistance exercise on physical performance and health-related quality of life in prostate cancer patients: a systematic review.Football training in men with prostate cancer undergoing androgen deprivation therapy: activity profile and short-term skeletal and postural balance adaptations.Effects of resistance exercise in prostate cancer patients: a meta-analysis.Group-based exercise in daily clinical practice to improve physical fitness in men with prostate cancer undergoing androgen deprivation therapy: study protocol.Exercise for people with cancer: a clinical practice guideline.Systematic review of the multidimensional fatigue symptom inventory-short form.Physical activity and advanced cancer: the views of oncology and palliative care physicians in Ireland.Can exercise suppress tumour growth in advanced prostate cancer patients with sclerotic bone metastases? A randomised, controlled study protocol examining feasibility, safety and efficacy.Feasibility of objectively measured physical activity and sedentary behavior in patients with malignant pleural effusion.The Independent Effects of Strength Training in Cancer Survivors: a Systematic Review.The use of exercise interventions to overcome adverse effects of androgen deprivation therapy.Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis.A pilot randomised controlled trial of a periodised resistance training and protein supplementation intervention in prostate cancer survivors on androgen deprivation therapy.Safety and feasibility of exercise interventions in patients with advanced cancer: a systematic review.Muscle mass as a target to reduce fatigue in patients with advanced cancer.Understanding strength exercise intentions and behavior in hematologic cancer survivors: an analysis of the intention-behavior gap.Effects of a 15-Month Supervised Exercise Program on Physical and Psychological Outcomes in Prostate Cancer Patients Following Prostatectomy: The ProRehab Study.Exercise for people with cancer: a systematic reviewCharacteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.The Effect of Nutrition Therapy and Exercise on Cancer-Related Fatigue and Quality of Life in Men with Prostate Cancer: A Systematic Review.Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer.Physical activity and advanced cancer: The views of chartered physiotherapists in Ireland.The views of patients with metastatic prostate cancer towards physical activity: a qualitative exploration.Associations between aerobic exercise levels and physical and mental health outcomes in men with bone metastatic prostate cancer: a cross-sectional investigation.A Focused Review of Safety Considerations in Cancer Rehabilitation.Exercise Preserves Physical Function in Prostate Cancer Patients with Bone Metastases.Oncology care provider perspectives on exercise promotion in people with cancer: an examination of knowledge, practices, barriers, and facilitators.Training-related improvements in musculoskeletal health and balance: a 13-week pilot study of female cancer survivors.Impact of physical exercise in cancer survivors during and after antineoplastic treatments.Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial.Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
P2860
Q26738281-5C993C73-D15C-429A-AB78-3C744AE4F9B6Q26799131-B756B11A-0021-4B05-93AA-1D6B3FB320A2Q34473328-4835CE9D-E0DA-45CF-AB2C-A71393870BB2Q35123662-D3C34C0D-1F48-4AF1-8946-CFB0A5A3A0FBQ35640064-5913C8EE-B820-4491-A001-DAC4E22561EDQ35856278-FB0B5DCF-CFF1-42EB-960F-532CB967748FQ36397349-3997DAA3-75D3-48C2-8BDF-DFE26F3C4C17Q37063622-142C7DB6-DEB3-4769-89AF-594CAC98C08FQ37672010-69C9CB60-18D4-4EA5-A95E-981642BB942EQ38241741-5CBE39EE-F612-4628-A07B-689674F23DA1Q38598340-B74D1E01-A8E6-4E77-80FE-19672A46D23EQ38676999-0BEE7C71-98EA-4B4E-AC8F-9852DF2E2E43Q38689520-730A2CAD-3581-4020-9C72-FC35E767444BQ38792801-881DA2E4-0980-4EEB-8115-290E58525C0AQ38817011-E07AA2CB-D22C-4FBD-B52C-3CEE519A680BQ39067972-A9DF807C-11FA-49E2-BD6C-017CBF9C4F35Q39429406-5DDD7F2E-0530-4097-8263-26FBCA577DCDQ39456393-81A199F1-0678-4B1A-8A85-3114EBD042D6Q40149999-30608088-182F-47DE-934A-58735B589BB8Q40496033-A2371D3C-1596-49A2-9DC7-E7D37373E244Q41007411-6C991BD6-943E-452A-BB85-60A3FEE8CB8BQ41559509-BC76000A-D7D2-4B78-B9CB-61CCDDAB5208Q41657822-E6E3DF8C-7ED1-4090-99F4-A555A55D48EFQ41942897-59615F5A-F251-4EA3-B0AF-7CFF3111BDFFQ43639151-872F5486-9DBA-4737-B633-A825064998F1Q47215030-84FAE5F4-6473-456D-A0A8-875F8ECD5933Q47305941-FFAA0B30-D599-4341-93C5-DC163D844F2AQ47933630-CB5E7BEB-8328-46DE-B62C-9947EEB214BCQ49886715-3B91F9E2-DC9C-459A-88AF-FD967B5EB35FQ50073960-A491982B-D843-4C0C-A9CB-B7A9CA88A92AQ50862712-91B61BE0-0D7B-4DC7-9BDB-A54CE7526154Q50941487-C0F77F5C-A026-4387-87FB-D236D6B7D866Q51732172-73CE725C-B5A4-4DE0-9C0F-FBB04C9A3437Q52573392-EA476A43-B148-43BA-A69B-4498A3C8F138Q53698798-CB1E17F9-6505-4EC0-A62C-278082631AF8
P2860
Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Safety and efficacy of resista ...... patients with bone metastases.
@en
Safety and efficacy of resista ...... patients with bone metastases.
@nl
type
label
Safety and efficacy of resista ...... patients with bone metastases.
@en
Safety and efficacy of resista ...... patients with bone metastases.
@nl
prefLabel
Safety and efficacy of resista ...... patients with bone metastases.
@en
Safety and efficacy of resista ...... patients with bone metastases.
@nl
P2093
P356
P1476
Safety and efficacy of resista ...... patients with bone metastases.
@en
P2093
P2888
P304
P356
10.1038/PCAN.2013.22
P577
2013-08-06T00:00:00Z